Fig. 5
From: Leukocyte telomere length serves as the novel prognostic biomarker for the resectable NSCLC
Post-LTL combined with TNM staging predicts the prognosis of resectable NSCLC. LTL combined with TNM staging analysis of OS (A) and DFS (C) in resectable NSCLC. ROC curves of 5-year OS (B) and DFS (D) in resectable NSCLC.
